Found 3814 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query: Glutamine Phosphoribosylpyrophosphate, subunit 1, domain 1

Total Genus Sequence Length pdb Title
501 1472 1ea0A Alpha subunit of a. brasilense glutamate synthase
70 244 5l5dB Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914
68 250 5l5dA Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914
69 243 5l5bF Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133)
69 242 5l5dD Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914
59 201 3unhK Mouse 20s immunoproteasome
44 196 3uneJ Mouse constitutive 20s proteasome
62 222 3tddH Crystal structure of yeast cp in complex with belactosin c
61 198 3tddJ Crystal structure of yeast cp in complex with belactosin c
57 204 3tddI Crystal structure of yeast cp in complex with belactosin c
71 212 3tddK Crystal structure of yeast cp in complex with belactosin c
64 233 1fntF Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution
138 459 1ao0A Glutamine phosphoribosylpyrophosphate (prpp) amidotransferase from b. subtilis complexed with adp and gmp
64 212 1fntL Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution
54 239 1fntD Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution
53 247 1fntB Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution
53 198 1fntK Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution
54 204 1fntJ Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution
62 240 1fntG Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution
47 238 1fntA Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution
59 244 1fntE Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution
55 241 1fntC Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution
56 222 1fntM Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution
51 222 1fntI Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution
62 241 5m2bG Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19
69 243 5m2bF Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19
60 195 5m2bJ Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19
58 226 5l6cH Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
69 213 5lf7L Human 20s proteasome complex with ixazomib at 2.0 angstrom
61 222 5m2bL Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19
60 195 5l5sJ Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924
65 211 5l6aK Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
69 244 5l60B Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
53 204 5lf0I Human 20s proteasome complex with epoxomicin at 2.4 angstrom
58 195 5l67J Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924
60 222 5l6bL Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914
58 195 5l63J Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
62 220 5lezH Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom
67 250 5l63A Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
69 242 5l66D Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib
62 211 5lttK Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924
67 233 5l64M Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
64 237 5lexC Native human 20s proteasome in mg-acetate at 2.2 angstrom
63 231 5l5vE 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
57 195 5l62J Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
65 230 5lf7A Human 20s proteasome complex with ixazomib at 2.0 angstrom
63 241 5lttG Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924
70 243 5l6bF Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914
67 240 5l5vC 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
70 240 5l62C Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16